Haiming Jiang1, Yejia Hu2, Li Shang3, Yuzhu Li3, Lihua Yang3, Yuguo Chen4. 1. Department of Emergency, Qilu Hospital, Shandong UniversityJinan, China; Yantai Affiliated Hospital of Binzhou Medical UniversityYantai, China. 2. School of Medical Science, Binzhou Medical University Yantai, China. 3. Yantai Affiliated Hospital of Binzhou Medical University Yantai, China. 4. Department of Emergency, Qilu Hospital, Shandong UniversityJinan, China; Chest Pain Center, Qilu Hospital, Shandong UniversityJinan, China; Institute of Emergency and Critical Care Medicine, Shandong UniversityJinan, China; Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Qilu Hospital, Shandong UniversityJinan, China; Key Laboratory of Cardiovascular Remodeling & Function Research, Chinese Ministry of Education & Chinese Ministry of Public Health, Qilu Hospital, Shandong UniversityJinan, China.
Abstract
OBJECTIVES: Idiopathic pulmonary fibrosis (IPF) is a group of lung diseases that cause irreversible architectural distortion and impair gas, and finally progressive pulmonary functional decline and death, in which the common variant in the promoter region of the mucin 5B (MUC5B) gene may be involved. The present study aims to investigate whether variants within the MUC5B gene rs35705950 contributed to IPF susceptibility and severity in Chinese Han Population. METHODS: A total of 187 patients diagnosed with IPF and 250 healthy controls were enrolled in this study. All subjects were genotyped for MUV5B SNP rs35705950. The demographic, comorbidity, clinical and functional data were recorded. RESULTS: The rs35705950 of MUC5B were found significantly associated with increased risk of IPF susceptibility. One way ANOVA analysis found that there was a significant decreased FVC (P < 0.0001) and DLco (P < 0.0001) in correction with the minor allele of the SNP rs35705950. In the 5 years' follow-up, the carriers of the minor allele T increased mortality (P = 0.0294). CONCLUSION: This study demonstrated that the MUC5B polymorphism rs35705950 is associated with increased risk of idiopathic pulmonary fibrosis susceptibility, severity, and the decreased overall survival.
OBJECTIVES:Idiopathic pulmonary fibrosis (IPF) is a group of lung diseases that cause irreversible architectural distortion and impair gas, and finally progressive pulmonary functional decline and death, in which the common variant in the promoter region of the mucin 5B (MUC5B) gene may be involved. The present study aims to investigate whether variants within the MUC5B gene rs35705950 contributed to IPF susceptibility and severity in Chinese Han Population. METHODS: A total of 187 patients diagnosed with IPF and 250 healthy controls were enrolled in this study. All subjects were genotyped for MUV5B SNP rs35705950. The demographic, comorbidity, clinical and functional data were recorded. RESULTS: The rs35705950 of MUC5B were found significantly associated with increased risk of IPF susceptibility. One way ANOVA analysis found that there was a significant decreased FVC (P < 0.0001) and DLco (P < 0.0001) in correction with the minor allele of the SNP rs35705950. In the 5 years' follow-up, the carriers of the minor allele T increased mortality (P = 0.0294). CONCLUSION: This study demonstrated that the MUC5B polymorphism rs35705950 is associated with increased risk of idiopathic pulmonary fibrosis susceptibility, severity, and the decreased overall survival.
Authors: Laurent Plantier; Bruno Crestani; Susan E Wert; Monique Dehoux; Barbara Zweytick; Andreas Guenther; Jeffrey A Whitsett Journal: Thorax Date: 2011-03-21 Impact factor: 9.139
Authors: Anna L Peljto; Mark P Steele; Tasha E Fingerlin; Monique E Hinchcliff; Elissa Murphy; Sofia Podlusky; Mary Carns; Marvin Schwarz; John Varga; David A Schwartz Journal: Chest Date: 2012-12 Impact factor: 9.410
Authors: Carmel J Stock; Hiroe Sato; Carmen Fonseca; Winston A S Banya; Philip L Molyneaux; Huzaifa Adamali; Anne-Marie Russell; Christopher P Denton; David J Abraham; David M Hansell; Andrew G Nicholson; Toby M Maher; Athol U Wells; Gisela E Lindahl; Elisabetta A Renzoni Journal: Thorax Date: 2013-01-15 Impact factor: 9.139
Authors: Imre Noth; Yingze Zhang; Shwu-Fan Ma; Dan Nicolae; Naftali Kaminski; Joe G N Garcia; Carlos Flores; Mathew Barber; Yong Huang; Steven M Broderick; Michael S Wade; Pirro Hysi; Joseph Scuirba; Thomas J Richards; Brenda M Juan-Guardela; Rekha Vij; MeiLan K Han; Fernando J Martinez; Karl Kossen; Scott D Seiwert; Jason D Christie Journal: Lancet Respir Med Date: 2013-04-17 Impact factor: 30.700
Authors: Yuejuan Li; Dianhua Jiang; Jiurong Liang; Eric B Meltzer; Alice Gray; Riu Miura; Lise Wogensen; Yu Yamaguchi; Paul W Noble Journal: J Exp Med Date: 2011-06-27 Impact factor: 14.307
Authors: Max A Seibold; Russell W Smith; Cydney Urbanek; Steve D Groshong; Gregory P Cosgrove; Kevin K Brown; Marvin I Schwarz; David A Schwartz; Susan D Reynolds Journal: PLoS One Date: 2013-03-20 Impact factor: 3.240
Authors: Raphael Borie; Bruno Crestani; Philippe Dieude; Hilario Nunes; Yannick Allanore; Caroline Kannengiesser; Paolo Airo; Marco Matucci-Cerinic; Benoit Wallaert; Dominique Israel-Biet; Jacques Cadranel; Vincent Cottin; Steven Gazal; Anna L Peljto; John Varga; David A Schwartz; Dominique Valeyre; Bernard Grandchamp Journal: PLoS One Date: 2013-08-05 Impact factor: 3.240
Authors: Louis Dagneaux; Aaron R Owen; Jacob W Bettencourt; Jonathan D Barlow; Peter C Amadio; Jean P Kocher; Mark E Morrey; Joaquin Sanchez-Sotelo; Daniel J Berry; Andre J van Wijnen; Matthew P Abdel Journal: J Arthroplasty Date: 2020-06-04 Impact factor: 4.757
Authors: Carlos Daniel Vasconcelos; António Carlos Ferreira; Patrícia Caetano Mota; Miguel Luz Soares; Bruno A Lima; Elisabetta Manduchi; Jason H Moore; Natália Melo; Hélder Novais-Bastos; José Miguel Pereira; Susana Guimarães; Conceição Souto Moura; José Agostinho Marques; António Morais Journal: J Mol Med (Berl) Date: 2022-08-19 Impact factor: 5.606
Authors: Ju Yang; Ting Xu; Daniel R Gomez; Melenda Jeter; Lawrence B Levy; Yipeng Song; Stephen Hahn; Zhongxing Liao; Xianglin Yuan Journal: Transl Oncol Date: 2017-02-09 Impact factor: 4.243
Authors: Paolo Spagnolo; Oliver Distler; Christopher J Ryerson; Argyris Tzouvelekis; Joyce S Lee; Francesco Bonella; Demosthenes Bouros; Anna-Maria Hoffmann-Vold; Bruno Crestani; Eric L Matteson Journal: Ann Rheum Dis Date: 2020-10-09 Impact factor: 19.103
Authors: Anna Stainer; Paola Faverio; Sara Busnelli; Martina Catalano; Matteo Della Zoppa; Almerico Marruchella; Alberto Pesci; Fabrizio Luppi Journal: Int J Mol Sci Date: 2021-06-10 Impact factor: 5.923